A method was developed for freeze-dry stabilization of poliovirus type 3. An ultrafiltration procedure was used to remove salts from infected tissue culture fluid, and the virus was freeze-dried after suspension in an alkaline organic buffer. This method was further tested with other picornaviruses including poliovirus types 1 and 2, coxsackieviruses A9, A20, B2, and B5, echovirus 11, and the encephalomyocarditis virus. Freeze-dried preparations of the poliovirus could be shipped to distant laboratories at ambient temperature with excellent retention of infectivity. Data are presented showing effects of freeze-drying as well as results of exposure to temperatures to 37 C.
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The preservation of enteroviruses by freezedrying has had little application because of generally unsuccessful attempts using empirical methods. Picornaviruses, with the exception of the rhinoviruses, have been found not to be easily preserved by lyophilization, with most of the original infectivity lost through this procedure (1). George and Gharpure (3) reported that lyophilization of coxsackievirus B4-infected muscle suspension and echovirus 7-infected tissue culture fluid resulted in 98.4 to 99% reduction in infectivity. Hammon (4) stated that laboratory evidence indicated inactivation of poliovirus after drying. Kraft and Pollard (5) found that poliovirus type 2-infected mouse brain tissue could be dried in the cold in various media with survival of up to one-third of the virus activity. However, their data indicated that residual infectivity of the dried virus preparation decreased sharply when the materials were held for as little as 20 min at temperatures of 30 C or higher.
At the American Type Culture Collection (ATCC), preservation of viruses and other biologic agents by freeze-drying, where it can be done successfully, is preferred to maintenance in the frozen state because of the greater convenience of handling and storage of dried cultures and the lower shipping costs involved in their distribution. This is an important consideration where enteroviruses comprise approximately 20% of more than 500 animal viruses maintained by ATCC, with distribution made to all parts of the world.
In a search for an effective stabilizer before the presently reported method was developed, many additives were tested for their effect on retention of infectivity of the tissue culture virus in the freeze-drying process. Bovine serum albumin (BSA), which has been used regularly in concentrations of 4.0 to 7.5 % as a protective compound in the lyophilization of arbovirus preparations, was detrimental to poliovirus at a concentration of 1.0%. Poliovirus freeze-dried in the presence of 4.0% BSA was completely inactivated. Addition of cryoprotective agents including highand low-molecular-weight dextrans (2 or 5%), polyvinylpyrrolidone (2, 5, or 10%), polyethylene glycol (2%), or dimethyl sulfoxide (2 or 5%) resulted in complete loss of poliovirus infectivity during the freeze-drying process. The incorporation of 10% skim milk in the medium before drying permitted some survival of virus, although more than 99.9% of the infectivity was lost. Greater retention of infectivity was found when any of a series of sugars or organic salts was added to the preparation. These included glucose, sucrose, lactose, the sucrose PG additive of Bovarnick et al. (2) , mannitol, inositol, sorbitol, sodium glycerophosphate, sodium glutamate, and calcium lactobionate. Sucrose PG or 10% lactose protected best against the adverse effects of drying, but even these permitted a 90% or greater loss in infectivity (unpublished data).
An additional problem, apparently not directly related to the freeze-drying process, was lack of stability of residual virus infectivity when the dried product was stored at temperatures higher than 4 Drying cycle. Two different freeze-drying machines were used; both gave comparable results. One was an American Sterilizer freeze-dryer model L-3 on which the shelf temperature was lowered to -40 to -55 C before serum bottles containing frozen virus material were loaded into the chamber. After a high vacuum was established, refrigeration was turned off and the samples were allowed to come slowly to ambient temperature (20 to 22 C) during the drying cycle. The bottles were sealed with nontoxic butyl rubber stoppers under high vacuum. The second machine was a Virtis modified horizontal manifold type with an alcohol-dry ice moisture trap and retrigerated alcohol circulated through troughs for control of product temperature. The initial temperature of the alcohol circulating in troughs bathing the ampoules was -30 to -40 C. The system was evacuated with a Precision 300 double stage vacuum pump. After a high vacuum was obtained, the refrigerating unit was turned off, allowing the temperature to rise slowly to 20 to 22 C. The ampoules were flame-sealed at atmospheric pressure after filling with dry nitrogen gas. Total drying time with both machines was 24 hr.
Conditions of test and assays. With few exceptions, at least two separate lots of each virus preparation were dried and tested with results reported as geometric mean titers. In cases where duplicate tests did not show agreement, additional lots were tested.
Dried samples were rehydrated using 0.5 ml of chilled, triple-distilled water. The rehydrated material was further diluted in serial 10-fold dilutions in the appropriate medium for the cell system being used in assays. Titers of samples were determined before and after freeze-drying and routinely after 5 days at 37 C. Other storage times and temperatures were occasionally tested.
All titrations were made in the tissue culture cell systems and media used for viral propagation except for poliovirus 3, which was tested in LLC-MK2 cells maintained with Melnick's B medium. Four tubes were used per dilution, and an inoculum of 0.2 ml per tube containing 0.8 ml of maintenance medium was used. Final readings for complete cytopathic effect were made 12 days after inoculation. The median tissue culture infective dose (TCD50) was calculated according to the method of Reed and Muench (6) .
Shipping trials. Samples of a freeze-dried preparation of poliovirus 3 were shipped by airmail without refrigeration to a series of cooperating laboratories for testing. Upon arrival in the laboratories, specimens were tested either on the same day or after storage in an ordinary refrigerator for periods ranging from 1 to 390 days. Titrations were made in primary or secondary monkey kidney cell cultures from rhesus or cynomolgus macaques or African green monkeys, as routinely employed in the individual participating laboratories.
RESULTS AND DISCUSSION
Repeated tests showed that poliovirus type 3 preparations could be lyophilized by the method outlined with relatively little loss of infectivity in contrast to results obtained with techniques previously employed. Geometric mean titer of frozen and thawed tissue culture seed virus preparations was 107-7 TCD50 per 0.2 ml; that of the freezedried materials was 107-4 TCD50. A specimen stored at 4 C for 24 weeks showed no decrease in titer.
A test lot of the type 3 poliovirus, prepared as described above in October 1968, was tested in shipping trials to determine stability of the dried virus under actual conditions without refrigeration. Results (Table 2) . In all instances, virus could be recovered from specimens held at 37 C for 5 days in accelerated deterioration tests. This temperature was chosen in part to simulate adverse conditions which might be encountered in tropical areas during shipment, but chiefly because residual infectivity of enteroviruses freeze-dried by other techniques was rapidly destroyed at this temperature and period of time.
Loss of infectivity at 37 C of the virus preparations dried by usual techniques was attributed to the presence of inorganic salts in the original tissue culture medium. When the infected tissue culture fluid was diluted 1,000-fold with distilled water to reduce concentration of compounds contained in the medium, that virus infectivity which remained after freeze-drying showed greater stability at 37 C than did the undiluted product. The same effect was found without concomitant reduction in virus titer imposed by dilution when the virus suspension was dialyzed against either cold Tris or distilled water prior to drying. Removal of salts was simplified by Diaflo filtration as described.
Tris buffer (1 M) provided better protection against loss of virus activity during the drying cycle than did any other material tested. Lower concentrations of Tris were less effective. The pH of Tris-virus mixture appeared to have little influence on virus infectivity retained during freeze-drying over the range of pH 7.5 through 10.0. Residual infectivity, however, showed greatest stability at 37 C in the products dried at pH 8.5 to 9.0, with 8.5 giving the most consistent protective effect.
